Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$540,000.00
Jul 1, 2025
For-profit organization
Materials for improved Cryoprotection of Cells and Cell Containing Devices
1034409
The current project advances the manufacturing readiness of Allarta’s Microgel Technology using scale-up engineering methodologies. Additionally, Allarta is extending the market penetration potential of its cell encapsulation devices through cold-chain solutions, allowing for the scale-up and commercial application of cell therapies beyond life-threatening illnesses which can bear the burden of ‘just-in-time’ production logistics.
$200,000.00
May 1, 2024
For-profit organization
Development of degradable Cryoprotective Agents for Cell-based Therapies
1020999
Non-cell permeating microgels are developed to promote cryopreservation with limited or no use of DMSO. This project aims to develop degradable microgels that are easy to separate from cell suspensions post-thawing. The microgels are being developed to work with a wide variety of cells and cell clusters.
$24,800.00
Sep 1, 2022
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
995086
The Project will support development of intellectual property capacity within the Firm.
$6,739.50
Aug 1, 2022
For-profit organization
Allarta Life Science Inc.-2022-2023-998642
998642
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
$10,500.00
May 1, 2022
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
990041
To help identify gaps in Allarta's existing intellectual property portfolio
$75,000.00
Oct 1, 2021
For-profit organization
Developing Robust Immune-Evasive Hydrogel Capsules for Cell Therapy
981387
Cell-based therapies for chronic disorders such as Type 1 Diabetes hold the promise of curative treatments. This project aims to developing robust yet immune-evasive hydrogel capsules to enable islet transplants in a mouse model.
$37,934.00
Dec 20, 2020
For-profit organization
Innovation Assistance Program – Round 2.5
966523
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$85,232.00
Jun 25, 2020
For-profit organization
Innovation Assistance Program – Round 2
960208
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$71,148.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
951693
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.